• Pazopanib (GW-786034) in Cancer Research: Workflows & Tips

  2026-05-09

  Pazopanib (GW-786034) streamlines tumor angiogenesis inhibition in vitro and in vivo, with unique sensitivity advantages in ATRX-deficient glioma models. This guide translates recent reference breakthroughs into actionable protocols and troubleshooting strategies for high-impact cancer research.

• HAX1 Modulates SARS-CoV-2 Spike-Induced ER Stress Responses

  2026-05-08

  This study uncovers HAX1 as a crucial mediator of the unfolded protein response (UPR) triggered by the SARS-CoV-2 spike protein in host cells. The work delineates how HAX1 limits reactive oxygen species accumulation and supports mitochondrial function, highlighting new host regulatory mechanisms relevant to coronavirus pathogenesis.

• Cefiderocol’s In Vitro Efficacy Against Resistant Gram-Negat

  2026-05-08

  This study presents the first large-scale, direct comparison of cefiderocol and modern β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp.—including multidrug-resistant strains. The findings clarify cefiderocol’s high activity profile and its role within evolving treatment strategies for Gram-negative bacterial infections.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Resear

  2026-05-07

  Difloxacin HCl stands out as a quinolone antimicrobial antibiotic with dual utility: enabling robust antimicrobial susceptibility testing and reversing multidrug resistance in oncology models. Its high solubility, reproducibility, and proven efficacy make it indispensable for translational researchers navigating both microbiology and cancer drug resistance challenges.

• Berberine Hydrochloride: Advanced Mechanisms & Protocols in

  2026-05-07

  Explore the multifaceted biochemical actions of Berberine hydrochloride, including its impact on the gut-bone axis, AMPK activation, and metabolic regulation. This article delivers an in-depth perspective on assay design, translational research, and practical workflow enhancements beyond existing coverage.

• DiscoveryProbe Bioactive Compound Library Plus: Applied Work

  2026-05-06

  The DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) empowers researchers with 5,072 rigorously validated small molecules for high-throughput screening, pathway analysis, and drug discovery. Explore practical protocols, advanced applications, and troubleshooting strategies to unlock reproducible, mechanistically insightful results—backed by robust peer-reviewed evidence and cross-domain innovations.

• Amorolfine Hydrochloride in Fungal Cell Integrity and Ploidy

  2026-05-06

  Explore how Amorolfine Hydrochloride advances antifungal reagent applications by revealing novel insights into fungal cell membrane disruption and ploidy regulation. This article delivers a unique, evidence-based perspective linking mechanism to experimental strategy.

• Paclitaxel (Taxol): Precision Cancer Research via Cell Cycle

  2026-05-05

  Explore how Paclitaxel (Taxol) advances cancer research by enabling precise cell cycle arrest at the G2-M phase, with new insights on protocol optimization and mechanistic depth. This article uniquely integrates recent signaling pathway research and practical guidance.

• Genistein in Experimental Oncology: Assay Design and Cytoske

  2026-05-05

  Explore how Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) enables precise inhibition of tyrosine kinases in cancer research. This article uniquely bridges cytoskeleton-dependent autophagy mechanisms with practical assay design, offering advanced guidance for experimental oncology.

• Drug-Sensitized Yeast Platform for High-Sensitivity mTOR Inh

  2026-05-04

  This study introduces a genetically engineered yeast system with enhanced drug sensitivity for the identification of mTOR inhibitors, achieving a remarkable increase in assay sensitivity compared to wild-type strains. The platform enables rapid, cost-effective screening of TOR pathway inhibitors, with precise differentiation between true inhibitors and compounds lacking TOR-targeted activity.

• Lactobacillus gasseri Modulates Colitis via NR1I3 and E-cadh

  2026-05-04

  Qian et al. (2024) demonstrate that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice by regulating the intestinal mucosal barrier through NR1I3-mediated E-cadherin expression. This mechanistic insight advances understanding of probiotic-based interventions for inflammatory bowel disease and highlights the critical role of epithelial integrity.

• K+ Channel Blockade Impacts Renal Blood Flow in Septic Rats

  2026-05-03

  This study systematically examines how blocking distinct potassium channel subtypes alters renal blood flow responses to vasoactive agents in septic rats. The work reveals that abnormal K+ channel function in sepsis complicates therapeutic strategies targeting vascular tone, with implications for both experimental design and translational research in vascular biology.

• ERK Inhibition Mitigates Autophagy via Mitochondrial Dynamic

  2026-05-02

  Yuan et al. (2023) elucidate how ERK inhibition protects neuronal cells from ischemia-reperfusion injury by modulating mitochondrial fragmentation and downregulating autophagy. Their findings clarify a mechanistic pathway relevant to neuroprotection and experimental autophagy research.

• Polybrene (Hexadimethrine Bromide): Optimizing Viral Gene De

  2026-05-02

  Polybrene (Hexadimethrine Bromide) amplifies viral gene transduction and DNA transfection efficiency, especially in challenging cell types. This guide offers a data-driven, protocol-centric roadmap for leveraging Polybrene’s unique properties, with actionable troubleshooting tips and cross-validated insights from recent mitochondrial metabolism research.

• GnRH Antagonists Modified with 3-(2-Methoxy-5-pyridyl)-alani

  2026-05-01

  This study introduces two novel degarelix analogs, each incorporating a diastereomeric form of 3-(2-methoxy-5-pyridyl)-alanine at position 3, to evaluate how stereochemistry affects GnRH receptor antagonism. The findings clarify structure-activity relationships critical for developing potent, long-acting peptide therapeutics targeting the reproductive axis.

16406 records 1/1094 page Next 12345 下5页 Last page